A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Last updated:
2026-07-25
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, SAFETY, AND EFFICACY STUDY OF RUXOLITINIB CREAM IN PEDIATRIC PARTICIPANTS WITH NONSEGMENTAL VITILIGO

Intervention/treatment:
RUXOLITINIB
Medical condition:
VITILIGO
Protocol code:
INCB 18424-312
Control number:
290802
Status:
Recruiting
Approved:
November 05, 2024
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT06548360
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
2 Years to 11 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Incyte Corporation Call Center (US)
Role
CONTACT
Phone:
1.855.463.3463
Name
Incyte Corporation Call Center (ex-US)
Role
CONTACT
Phone:
+800 00027423
Sponsor
INCYTE CORPORATION

Locations

Alberta

Alberta Dermasurgery Centre
Edmonton, Alberta, T6G 1C3
RECRUITING
Alberta Health Services (Ahs) - Alberta Children'S Hospital (Ach)
Calgary, Alberta, T3B 6A8
RECRUITING
Dermatology Research Institute
Calgary, Alberta, T2J 7E1
RECRUITING
Kirk Barber Research
Calgary, Alberta, T2G 1B1
RECRUITING
Laser Rejuvenation Clinics Edmonton D.T. Inc
Edmonton, Alberta, T5J 3S9
RECRUITING
Skin Physicians
Edmonton, Alberta, T6W 4V4
NOT_YET_RECRUITING

British Columbia

Coal Harbour Rejuvenation Dermatology, Inc.
Vancouver, British Columbia, V6C 0C3
RECRUITING

Manitoba

Winnipeg Clinic
Winnipeg, Manitoba, R3C 1T6
RECRUITING

Nova Scotia

Maritime Dermatology
Halifax, Nova Scotia, B3K5R3
RECRUITING

Ontario

Cosmetic Dermatology on Bloor
Toronto, Ontario, M5S 3B4
RECRUITING
Dar Clinical Research Inc
Ottawa, Ontario, K2T 0N7
RECRUITING
Dermcare Clinic
Mississauga, Ontario, L4W 0C2
NOT_YET_RECRUITING
University of Toronto - the Hospital For Sick Children (Sickkids)
Toronto, Ontario, M5G1X8
RECRUITING

Quebec

Centre de Recherche Saint-Louis
Québec, Quebec, G1W 4R4
RECRUITING
Centre de Recherche St-Louis
Montreal, Quebec, H1Y 3L1
RECRUITING
Centre Hospitalier Universitaire de Quebec - Centre Hospitalier de L'Universite Laval (Chul)
Québec, Quebec, G1V 4G2
RECRUITING
Universite de Montreal - Centre Hospitalier Universitaire (Chu) Sainte-Justine - Centre de Recherche
Montreal, Quebec, H3T 1C5
RECRUITING

Saskatchewan

Saskatoon Dermatology Centre
Saskatoon, Saskatchewan, S7T 0G3
RECRUITING
Skincare Studio Dermatology Centre
St. John's, Saskatchewan, A1E 1V4
RECRUITING
Did you find what you were looking for?